Subsequent studies in melanoma revealed a direct role for the BRAFV600E mutation: Expression of mutant BRAF was sufficient to upregulate cyclin D1 and downregulate p27 in human melanocytes [54], while in melanoma cells, mutant B-RAF controls p27Kip1 expression via mRNA abundance and proteasomal degradation [55]. Here, BRAF is linked to melanoma.